Vaccination with HPV16 Peptides of Patients with Advanced Cervical Carcinoma: Clinical Evaluation of a Phase I-II Trial

By van Driel W.J.   Ressing M.E.   Kenter G.G.   Brandt R.M.P.   Krul E.J.T.   van Rossum A.B.   Schuuring E.   Offringa R.   Bauknecht T.   Tamm-Hermelink A.   van Dam P.A.   Fleuren G.J.   Kast W.M.   Melief C.J.M.   Trimbos J.B.  

European Journal of Cancer, Vol. 35, Iss. 6, 1999-06 ,pp. : 946-952

Elsevier

Access to resources Recommend Favorite

Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group

By Aapro M.S.   van Wijk F.H.   van der Burg M.E.L.   ten Bokkel Huinink W.   Vergote I.   Guastalla J.P.   Rosso R.   Kobierska A.   Beex L.V.A.   Namer M.   Splinter T.E.W.   Vermorken J.B.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1141-1143

Elsevier

Access to resources Recommend Favorite

Combined Carboplatin plus Ifosfamide and Cisplatin in Patients with Advanced Ovarian Carcinoma. A Phase I-II Study

By Lorusso V.   Leone B.   Di Vagno G.   Manzione L.   Palmeri S.   Vallejo C.   Machiavelli M.   Nacci G.   Bilancia D.   Leonardi V.   Catino A.   Gargano G.   Loverro G.   Selvaggi L.   De Lena M.  

Gynecologic Oncology, Vol. 68, Iss. 2, 1998-02 ,pp. : 172-177

Elsevier

Access to resources Recommend Favorite

Can Serum CA-125 Levels Predict the Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma?

By Saygili U.   Guclu S.   Uslu T.   Erten O.   Demir N.   Onvural A.  

Gynecologic Oncology, Vol. 86, Iss. 1, 2002-07 ,pp. : 57-61

Academic Press

Access to resources Recommend Favorite

Idiotype Vaccination of Myeloma Patients After Chemotherapy

By Massaia Massimo  

Acta Oncologica, Vol. 39, Iss. 7, 2000-11 ,pp. : 807-808

Informa Healthcare

Access to resources Recommend Favorite